1-3 of 3
Jose-Luis Fuster, MD
Close
Sort by
Journal Articles

Results of PETHEMA LAL-BR-01 Protocol for Low-Risk (LR) Acute Lymphoblastic Leukemia (ALL) In Children

Josep-Maria Ribera, MD, PhD, Albert Oriol, MD, Mireia Morgades, PhD, Pilar Bastida, MD, Olga Garcia, PhD, Alvaro Lasaletta, MD, Jose-Luis Fuster, MD, Elvira Gonzalez-Valentin, MD, Inmaculada Soto, MD, Ana Carbone, MD, Antonio Molines, MD, Izaskun Egurbide, MD, Andres Llorente, MD, Esmeralda Benitez, MD, Luis Madero, MD, PhD, Jose Sanchez de Toledo, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4334.
https://doi.org/10.1182/blood.V116.21.4334.4334
Published: 2010
Journal Articles

One Year Reinductions with Vincristine, Asparaginase and Prednisone as Post-Remission Therapy Improves Outcome in Children with Intermediate Risk (IR) Acute Lymphoblastic Leukemia (ALL).

Albert Oriol, MD, Pilar Bastida, MD, Olga García, Carlota Calvo, Juan-Manuel Perez-Hurtado, Maria-Elvira González Valentin, Jose Luis Fuster, MD, Izaskun Egurbide, Victoria Martin-Reina, Antonio Molines, MD, Javier Lassaletta, Miguel-Angel Sanz, Mar Tormo, Mercedes Carnero, Juan-José Ortega, Josep-Maria Ribera, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2026.
https://doi.org/10.1182/blood.V114.22.2026.2026
Published: 2009
Journal Articles

Treatment with All- Trans Retinoic Acid and Anthracycline Monochemotherapy in Children with Acute Promyelocytic Leukemia: Analysis of Three Sequential Multicenter Trials of the PETHEMA Group

Luis Madero, Pau Montesinos, MD, Pilar Bastida, MD, Amparo Verdeguer, MD, Javier De la Serna, MD, Antonio Molines, MD, Purificacion Garcia, MD, Jose Luis Fuster, MD, Maria jose Allegue, MD, Rafael Rojas, MD, Miguel A. Sanz, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 137.
https://doi.org/10.1182/blood.V112.11.137.137
Published: 2008